Chemoinformaics analysis of Ethyl 3,3-dimethylacrylate
| Molecular Weight | 128.171 | nRot | 2 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 2 |
| Exact Molecular Weight | 128.084 | nRing | 0 |
| Solubility: LogS | -1.758 | nHRing | 0 |
| Solubility: LogP | 2.133 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 21.2955 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.416 |
| Synth | 2.134 |
| Natural Product Likeliness | 0.726 |
| NR-PPAR-gamma | 0.045 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.014 |
| HIA | 0.002 |
| CACO-2 | -4.18 |
| MDCK | 0.0000321 |
| BBB | 0.996 |
| PPB | 0.581117 |
| VDSS | 1.124 |
| FU | 0.578918 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.896 |
| CYP2c19-inh | 0.845 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.472 |
| CYP2c9-sub | 0.384 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.303 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.334 |
| CL | 9.69 |
| T12 | 0.8 |
| hERG | 0.009 |
| Ames | 0.008 |
| ROA | 0.02 |
| SkinSen | 0.925 |
| Carcinogencity | 0.258 |
| EI | 0.983 |
| Respiratory | 0.163 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.952486 |